Pharmaxis's mannitol filed for cystic fibrosis in the EU
This article was originally published in Scrip
Executive Summary
Pharmaxis has applied for the approval of Bronchitol, its inhaled dry-powder formulation of mannitol, in the EU, for the treatment of cystic fibrosis.